Ewing Sarcoma Breakpoint Region 1 (EWSR1) Peptide
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Ewing Sarcoma Breakpoint Region 1 (EWSR1) Peptide is a synthetic peptide.
Documents del producto
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | Ewing Sarcoma Breakpoint Region 1 (EWSR1) |
| Host | Synthetic |
| Recommended Dilution | BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Observed MW | Sequence Fragment: Internal region: C-TSYDQSSYSQQNTYG |
| Size 1 | 100 µg |
| Form | Lyophilized Reconstitute in deionized water. |
| Tested Applications | P-ELISA |
| Buffer | Prior to lyophilization: Deionized water. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Gene ID | 2130, 14030, 289752 |
| NCBI Accession | NP_053733.2, NP_005234.1, NP_001156757.1, NP_001156758.1, NP_001156759.1 |
| Background | Protein EWSR1 |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products
EWSR1 antibody
Ver ProductoEWSR1 antibody
Ver Producto
Ewing Sarcoma Breakpoint Region 1 (EWSR1) Antibody
EWSR1 Antibody is a Rabbit Polyclonal antibody against EWSR1. This gene encodes a multifunctional protein that is involved in various cellular processes, including gene expression, cell signaling, and RNA processing and transport. The protein includes an N-terminal transcriptional activation domain and a C-terminal RNA-binding domain. Chromosomal translocations between this gene and various genes encoding transcription factors result in the production of chimeric proteins that are involved in tumorigenesis. These chimeric proteins usually consist of the N-terminal transcriptional activation domain of this protein fused to the C-terminal DNA-binding domain of the transcription factor protein. Mutations in this gene, specifically a t(11;22)(q24;q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 1 and 14.
Ver Producto